A sharp Mind, a Great Life: The Story of Jim Tananbaum

“Success is no accident. It is hard work, perseverance, learning, studying, sacrifice and most of all, love of what you are doing or learning to do.” These famous words by Pele define the life of a highly successful person. Jim Tananbaum is a man that has defied all odds and emerged victoriously. The alumnus of the Harvard Business School, the Harvard Medical School, Yale University, and the Massachusetts Institute of Technology is not only an established founder but a designated corporate head. Because Jim has always been an insightful person, he has helped create GelTex, Sierra Ventures, Theravance, Prospect Venture Partners, and Foresite Capital Management.

For a long time, Jim Tananbaum has been passionate about improving healthcare. As a result, he has used resources in Foresite Capital Management to raise funds, and awareness sought to help better neuropsychiatric diagnosis and treatment. By making use of the Mindstrong’s Al-powered platform, Foresite Capital Management in partnership with ARCH Venture Partners, One Mind Brain Health Impact Fund, Palo Alto, Berggruen Holdings, and Optum Ventures was able to raise $14 million for the drive.

Using the funds, a set of clinical trials got initiated, but the results are yet to get released. If proven to be successful, Mindstrong’s approach using technology will be able to diagnose and treat neuropsychiatric ailments by the use of Smartphones. In an article on Medium.com, Mindstrong, through the assistance of partners like Jim Tananbaum’s Foresite Capital Management, are adopting modern approaches to treat brain disorders by monitoring the functionality of the organ using Smartphones. Mindstrong was chosen to head the program mainly because it has proven over time to understand the various challenges that patients with cognitive health disorders encounter on a daily basis.

Thanks to Jim Tananbaum’s efforts, brain health is looking on the upright. Mindstrong is borrowing templates from actual procedures used for diabetes and heart disease. Gone will be the days when mental health will only get tested through clinical trials. It is a move in the right direction, meaning that fewer mental patients will get stigmatized. Also, the technology will help create a cure for Neuropsychiatric disorders.

Read More: https://ideamensch.com/jim-tananbaum/

Leave a Reply

Your email address will not be published. Required fields are marked *